Golden Meditech Announces FY2019/2020 Annual Results
Revenue Fluctuated during the Pandemic, The Group is Confident to Meet Future Challenges Sustainable Growth in Beijing Sunbow O&G Hospital, Interim Achievements in Cell Therapy Clinical Trials For the Year Ended 31 March 2020 (HK$'000) 2019 (HK$'000) Change (%) Revenue 307,141 315,66...
Golden Meditech's Associate, Cellenkos, Focuses on the Development of Cell-theray for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)
HONG KONG, March 18, 2020 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise inChina, announced that its associate, Cellenkos, Inc. ("Cellenkos") has submitted a clinical development proposal to the Biomedical ...
Golden Meditech Announces FY2019/2020 Interim Results
Revenue Fluctuated Amidst the Challenging Market Conditions Significant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ -- For the Six Months Ended 30 September 2019 (HK$'000) 2018 (HK$'000) Change (%) Revenue 157,2...
Golden Meditech Announces FY2018/2019 Annual Results
HONG KONG, June 28, 2019 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801)("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, announces today its annual results for the year ended31 March 20...
Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons
New Members on Board, the Company's Major Shareholder Maintains Full Confidence in Future Business Development HONG KONG, May 24, 2019 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a l...
Golden Meditech and HKBU Team Up to Conduct Cell Therapy Research
HONG KONG, April 17, 2019 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise inChina, announced that it has formed a collaboration with the Department of Biology of Hong KongBaptist University ("HKBU") to condu...
Golden Meditech Announces FY2018/2019 Interim Results
Focusing on Business Diversification Strategies and Achieved Double-Digit Group Revenue Growth Newly-established Businesses in Healthcare Services Grew Rapidly and Strategic Investment Projects On-track HONG KONG, Nov. 26, 2018 /PRNewswire/ -- For the Six Months Ended 30 September 2018 (HK...
Golden Meditech Announces FY2017/2018 Annual Results
Healthcare Services Business Achieves Organic Growth and Diversification Newly Start-up Cells and Tissues Storage and Genetic Testing Services Completes Our Entry into the Biomedical Industry HONG KONG, June 27, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Gol...
Golden Meditech's Associate, Cellenkos Names Alick Sun as Corporate & Business Development SVP
HONG KONG, April 16, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, announced that its associate, Cellenkos, Inc. ("Cellenkos") ha...
Golden Meditech's Largest Shareholder Further Increased Shareholdings
HONG KONG, March 19, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, is pleased to announce that the Company's largest shareholder ...
Golden Meditech's Largest Shareholder Acquired Additional 9,068,000 Shares
HONG KONG, March 14, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, is pleased to announce that the Company's largest shareholder ...
Golden Meditech's Subsidiary Completes Acquisition of 50% Equity Interest in ASA
HONG KONG, Feb. 28, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise inChina, announces that Golden Meditech K.K., an indirect wholly-owned subsidiary of the Company, has completed the a...
Golden Meditech Lays Out Strategic Plan across the Value Chain in the Emerging Biomedical Industry
HONG KONG, Feb. 26, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, is pleased to announce that Shanghai GM Diagnosis Co., Ltd.* ("...
Golden Meditech Declares a Special Dividend to Shareholders
HONG KONG, Feb. 13, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise inChina, is pleased to announce that the board of directors of the Company (the "Board") declares a special cash dividend ofHK$0.30 per sh...
Golden Meditech Announces FDA Registration of GMP Manufacturing Facility by its Associate, Cellenkos, Inc.
HONG KONG, Feb. 7, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise inChina, announces that its associate, Cellenkos, Inc. ("Cellenkos") successfully registered its stand-alone, manufacturing facility as...
Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund
HONG KONG, Feb. 4, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, announces that Golden Meditech Technology (Shanghai) Company Lim...
Golden Meditech Announces Close of Repurchase of TDR for the Delisting of TDR on TWSE
HONG KONG, Feb. 1, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise inChina, announces today the TDR repurchase period is closed on January 31, 2018 , regarding the proposed voluntary delisting of theTaiwan d...
Golden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation
HONG KONG, Jan. 31, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"), a leading integrated healthcare enterprise inChina, is pleased to announce that the sale of 65.4% of the issued share capital of China Cord Blood Corporation to Nanjing Yingpeng Hui...
Golden Meditech Announces FY2017/2018 Interim Results
Qinghe Hospital Achieves Revenue Contribution, Significant Growth in Healthcare Services Business Strategic Roadmap in the Advanced Medical Fields to Diversify the Group's Business and Revenue Stream HONG KONG, Nov. 30, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 0080...
Golden Meditech and GE Healthcare Team Up to Develop Safe and Efficient Cord Blood Storage Services
HONG KONG, Nov. 16, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise inChina, today announces that it has formed ...
